SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) reported a net loss for the three months ended September 30, 2008 of $17.1 million, or $0.31 per share (on 55.3 million weighted-average shares), compared to a net loss of $13.3 million, or $0.34 per share (on 39.6 million weighted-average shares), for the same period in 2007. The Company reported a net loss for the nine months ended September 30, 2008 of $45.7 million, or $0.96 per share (on 47.8 million weighted-average shares), compared to a net loss of $38.7 million, or $1.04 per share (on 37.2 million weighted-average shares), for the same period in 2007.
